Animal healthcare firm Hester Biosciences on Friday posted a four per cent decline in its consolidated profit at ₹11.9 crore for the quarter ended December 31, 2019.
The company had posted a consolidated profit of ₹12.4 crore in the year-ago period, Hester Biosciences said in a filing to BSE.
The consolidated revenue of the company, however, increased to ₹50.9 crore in the October-December period, over ₹45.9 crore in the year-ago period, the filing saidPTI SID
Shares of Hester Biosciences were trading at ₹1,610, down 1.67 per cent on the BSE.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.